Search Results - "Cannon, Kristine"

  • Showing 1 - 8 results of 8
Refine Results
  1. 1

    Microbiology of cardiac implantable electronic device infections in Calgary, Canada by King, Teagan, Chew, Derek S, Leal, Jenine, Cannon, Kristine, Zhang, Zuying, Rennert-May, Elissa

    “…The microbiology of cardiac implantable electronic device (CIED) infections in Calgary, Alberta was described, identifying 50 infections from 2013 to 2019. The…”
    Get full text
    Journal Article
  2. 2

    The economic burden of cardiac implantable electronic device infections in Alberta, Canada: a population-based study using validated administrative data by Rennert-May, Elissa, Chew, Derek, Cannon, Kristine, Zhang, Zuying, Smith, Stephanie, King, Teagan, Exner, Derek V, Larios, Oscar E, Leal, Jenine

    “…Cardiac implantable electronic devices (CIED) are being inserted with increasing frequency. Severe surgical site infections (SSI) that occur after device…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Subacute sclerosing panencephalitis in pregnancy by Chiu, Michael H, MD, Meatherall, Bonnie, MD, Nikolic, Ana, MD, Cannon, Kristine, MBT, Fonseca, Kevin, PhD, Joseph, Jeffrey T, PhD, MacDonald, Judy, MD, Pabbaraju, Kanti, MSc, Tellier, Raymond, MD, Wong, Sallene, BSc, Koch, Marcus W, Dr

    Published in The Lancet infectious diseases (01-03-2016)
    “…Summary We present a case of subacute sclerosing panencephalitis that developed in a previously healthy 29-year-old pregnant woman who had returned from a trip…”
    Get full text
    Journal Article
  5. 5

    Enteric microbiome profiles during a randomized Phase 2 clinical trial of surotomycin versus vancomycin for the treatment of Clostridium difficile infection by Cannon, Kristine, Byrne, Brendan, Happe, Jennifer, Wu, Kaiyu, Ward, Linda, Chesnel, Laurent, Louie, Thomas

    Published in Journal of antimicrobial chemotherapy (01-12-2017)
    “…The effects of surotomycin (CB-183,315, MK-4261), a bactericidal cyclic lipopeptide, and vancomycin, the current standard-of-care for Clostridium difficile…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Differences of the Fecal Microflora With Clostridium difficile Therapies by Louie, Thomas J., Byrne, Brendan, Emery, Judith, Ward, Linda, Krulicki, Wally, Nguyen, David, Wu, Kaiyu, Cannon, Kristine

    Published in Clinical infectious diseases (15-05-2015)
    “…Background. During treatment of Clostridium difficile infection (CDI), patterns of pathogen reduction in relationship to changes in components of the normal…”
    Get full text
    Journal Article
  8. 8